Compliance news, white papers, reports, and events from PharmaLeaders. New content daily, on our website and delivered right to your inbox.
GDUFA III will need to be enacted by Congress in order to take effect at the start of fiscal 2023, which begins on Oct. 1, 2022.Read More
Medical Science Liaisons (MSL) in the pharma industry were already at their limit pre-COVID. The challenge for MSLs is to identify the most efficient way to upskill their teams and add digital competencies without overloading them.Read More
One of the most important obligations for researchers seeking UK clinical trial approval is to determine from the start how they will disseminate their study results publicly.Read More
Authored and contributed to PharmaLeaders by Jeff Pool, VP of Revenue at Florence Healthcare Failed remote site access and monitoring attempts have left study sites with a computer full of access portals, FTP logins, document vaults, and emails. Why do sponsor remote site access and monitoring rollouts fail? Because the sponsor focuses on solving their access problems ...Read More
The 2020s will transform how consumers and businesses interact with each other as vast amounts of personal and contextually relevant data will be generated. These changes will demand organizations implement a new framework for deploying and managing communications, for implementing innovative omnichannel marketing strategies and tools, and for acquiring and utilizing data. This whitepaper explains how to ...Read More
As healthcare marketers strive to keep pace with data technologies for better targeting and conversion, budgeting for 2019 becomes a formidable challenge. Questions about competitive advantages and cost-effectiveness drive conversations. Yet, the focus of forward-thinkers is shifting to better data for targeting faster and sooner in the engagement lifecycle. “We are seeing a dramatic increase in ...Read More